Company Filing History:
Years Active: 2004-2009
Title: **Amy Chang-Murad: Innovator in Protein Production**
Introduction
Amy Chang-Murad is a notable inventor based in DeRidder, Louisiana, recognized for her contributions to the field of protein production. With two patents to her name, she has made significant advancements in recombinant technology, which holds immense potential for therapeutic applications.
Latest Patents
Her latest patents include innovative methods for producing and purifying critical proteins. The first patent, titled "Method of Producing and Purifying Endostatin Protein," outlines a technique for the recombinant production, recovery, and purification of endostatin protein. This method is designed for large-scale recovery, making it crucial for further research and clinical applications in cancer treatment.
The second patent, "Method of Producing and Purifying Angiostatin," similarly provides methods for the recombinant production, recovery, and purification of angiostatin protein. Like her endostatin methods, this approach is expected to facilitate large-scale production, thereby enhancing the prospects for research involving angiostatin in therapeutic settings.
Career Highlights
Throughout her career, Amy has worked with several prominent organizations, including Entremed, Inc. and Children's Medical Center Corporation. Her roles at these companies have involved groundbreaking research and development in the field of molecular biology and therapeutics.
Collaborations
Amy Chang-Murad has also collaborated with esteemed professionals such as John W. Madsen and Hong Liang. These partnerships have facilitated the advancement of her research and further contributed to the success of her patented technologies.
Conclusion
In conclusion, Amy Chang-Murad stands out as an exceptional inventor, making significant strides in the production and purification of vital therapeutic proteins. Her patents not only advance scientific knowledge but also promise to lead to innovative treatments in the medical field. As she continues her work, the impact of her contributions will undoubtedly resonate in the realms of biotechnology and medicine.